West Branch Capital LLC Novartis Ag Transaction History
West Branch Capital LLC
- $234 Million
- Q1 2024
A detailed history of West Branch Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, West Branch Capital LLC holds 200 shares of NVS stock, worth $21,612. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$21,612
Previous $20,000
5.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,350Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.34 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.33 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$784 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$650 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$639 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $232B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...